About Aleks Radovic-Moreno
Form D filings for Progentos Therapeutics in 2024 list Aleks Radovic-Moreno as director.
Aleks Radovic-Moreno first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Aleks Radovic-Moreno in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Aleks Radovic-Moreno works with at each company, as listed on that company's latest Form D.
Progentos Therapeutics, Inc. · Form D, May 17, 2024
DH
Dmitrij Hristodorov
Director
DJ
Dan Janney
Director
CL
Christopher Loose
CEO and director
CB
Cassidy Blundell
Director
SM
Sanjay Magavi
Executive officer
MT
Marc-Olivier Turgeon
Director